Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A common cough medicine may slow cognitive decline in people with Parkinson’s disease dementia, a clinical trial has revealed ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

A multi-strain probiotic blend shows promise for protecting brain function by reducing gut-triggered inflammation linked to ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests.Nearly half of those diagnosed with Parkinson’s ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.

A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

The active ingredient in Ozempic was associated with a reduced risk of Alzheimer's disease-related dementia among diabetes ...

New immunotherapy drugs offer some hope in the fight against Alzheimer's disease but they're too pricey for the NHS ...